微电生理: 第三届监事会第十六次会议决议公告

Group 1 - The supervisory board of Shanghai MicroPort CardioFlow Medtech Corp. held its 16th meeting of the third session on August 26, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The supervisory board approved the company's 2025 semi-annual report, stating that it accurately reflects the company's operational status without any false records or omissions [1][2] - The board confirmed that the company has managed and used raised funds in accordance with regulations, ensuring no harm to shareholder interests [2][3] Group 2 - The supervisory board agreed to use part of the temporarily idle raised funds for cash management, which is expected to enhance fund efficiency without affecting normal operations or investment projects [2][3] - The decision to manage idle funds was unanimously supported by the supervisory board, with all votes in favor [2][3]